TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TAS1553, a small molecule subunit interaction inhibitor of ribonucleotide reductase, exhibits antitumor activity by causing DNA replication stress
Authors
Keywords
-
Journal
Communications Biology
Volume 5, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-09
DOI
10.1038/s42003-022-03516-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure-guided design of anti-cancer ribonucleotide reductase inhibitors
- (2019) Tessianna A. Misko et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies
- (2019) Junko Murai et al. PHARMACOLOGY & THERAPEUTICS
- Randomized, Double-Blind, Phase II Study of Temozolomide in Combination With Either Veliparib or Placebo in Patients With Relapsed-Sensitive or Refractory Small-Cell Lung Cancer
- (2018) M. Catherine Pietanza et al. JOURNAL OF CLINICAL ONCOLOGY
- Structure-Guided Synthesis and Mechanistic Studies Reveal Sweetspots on Naphthyl Salicyl Hydrazone Scaffold as Non-Nucleosidic Competitive, Reversible Inhibitors of Human Ribonucleotide Reductase
- (2018) Sarah E. Huff et al. JOURNAL OF MEDICINAL CHEMISTRY
- TAS-114, a First-in-Class Dual dUTPase/DPD Inhibitor, Demonstrates Potential to Improve Therapeutic Efficacy of Fluoropyrimidine-based Chemotherapy
- (2018) Wakako Yano et al. MOLECULAR CANCER THERAPEUTICS
- TAS6417, A Novel EGFR Inhibitor Targeting Exon 20 Insertion Mutations
- (2018) Shinichi Hasako et al. MOLECULAR CANCER THERAPEUTICS
- SLFN11 Blocks Stressed Replication Forks Independently of ATR
- (2018) Junko Murai et al. MOLECULAR CELL
- Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia
- (2018) Xin Xu et al. CELLULAR ONCOLOGY
- Potent competitive inhibition of human ribonucleotide reductase by a nonnucleoside small molecule
- (2017) Md. Faiz Ahmad et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ATR inhibition facilitates targeting of leukemia dependence on convergent nucleotide biosynthetic pathways
- (2017) Thuc M. Le et al. Nature Communications
- Genetic visualization of protein interactions harnessing liquid phase transitions
- (2017) Taku Watanabe et al. Scientific Reports
- Allosteric Inhibition of Human Ribonucleotide Reductase by dATP Entails the Stabilization of a Hexamer
- (2016) Nozomi Ando et al. BIOCHEMISTRY
- SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia
- (2016) Constanze Schneider et al. NATURE MEDICINE
- Cancer metabolism pipeline breaks new ground
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma
- (2016) Kelli L. Goss et al. Oncotarget
- Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators
- (2015) Md. Faiz Ahmad et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ribonucleotide Reductase Subunit M2 Predicts Survival in Subgroups of Patients with Non-Small Cell Lung Carcinoma: Effects of Gender and Smoking Status
- (2015) Vei Mah et al. PLoS One
- RPA-coated single-stranded DNA as a platform for post-translational modifications in the DNA damage response
- (2014) Alexandre Maréchal et al. CELL RESEARCH
- Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies
- (2014) Y Aye et al. ONCOGENE
- Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
- (2014) Roland Nilsson et al. Nature Communications
- A Small-Molecule Blocking Ribonucleotide Reductase Holoenzyme Formation Inhibits Cancer Cell Growth and Overcomes Drug Resistance
- (2013) B. Zhou et al. CANCER RESEARCH
- Targeting ribonucleotide reductase for cancer therapy
- (2013) Jimin Shao et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Heterogeneity of tumor-induced gene expression changes in the human metabolic network
- (2013) Jie Hu et al. NATURE BIOTECHNOLOGY
- Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
- (2013) Lars Petter Jordheim et al. NATURE REVIEWS DRUG DISCOVERY
- Management of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone-induced methemoglobinemia
- (2012) Charles A Kunos et al. Future Oncology
- Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
- (2012) G. Zoppoli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- iMOSFLM: a new graphical interface for diffraction-image processing withMOSFLM
- (2011) T. Geoff G. Battye et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Structural basis for allosteric regulation of human ribonucleotide reductase by nucleotide-induced oligomerization
- (2011) James Wesley Fairman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Clofarabine 5'-di and -triphosphates inhibit human ribonucleotide reductase by altering the quaternary structure of its large subunit
- (2011) Y. Aye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer
- (2009) Gabriella Ferrandina et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A LC-MS/MS Method for the Analysis of Intracellular Nucleoside Triphosphate Levels
- (2009) Ping Chen et al. PHARMACEUTICAL RESEARCH
- Broad Overexpression of Ribonucleotide Reductase Genes in Mice Specifically Induces Lung Neoplasms
- (2008) X. Xu et al. CANCER RESEARCH
- The Structural Basis for Peptidomimetic Inhibition of Eukaryotic Ribonucleotide Reductase: A Conformationally Flexible Pharmacophore†
- (2008) Hai Xu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hydroxyurea for the Treatment of Sickle Cell Anemia
- (2008) Orah S. Platt NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now